Medicines used in nasal diseases. Anti-oedemic and other drugs for topical use in nasal diseases
Xylometazoline is a sympathomimetic agent that acts on α-adrenergic receptors. Xylometazoline, when administered nasally, causes narrowing of the blood vessels of the nasal mucosa and paranasal sinuses, thus eliminating oedema and hyperemia of the nasal mucosa and nasopharynx, as well as reducing the associated increased mucus secretion and facilitating the removal of mucous membranes. nasal passages and facilitate nasal breathing.
Symptomatic treatment of nasal congestion in colds, hay fever, other allergic rhinites, sinusites.
To facilitate the outflow of secretions in sinusitis.
Adjuvant therapy for otitis media (to eliminate mucosal swelling).
To facilitate rhinoscopy.
Rinazal, nasal metered-dose spray, 0.5 mg/ml:
It is prescribed to children from 2 to 5 years old (under the supervision of adults) with 1 spray into each nostril 1–2 times per day. It should be used no more than 3 times in each nostril daily.
It is prescribed to children from 6 to 11 years old (under the supervision of adults) with 1–2 sprays into each nostril 2–3 times per day. It should be used no more than 3 times in each nostril daily.
The duration of treatment depends on the course of the disease and should not exceed 7–10 consecutive days.